SCHEMBL270549

SCHEMBL270549

CCCCCCCCCCCCCCCC(=O)OC(C)(CC)CCCC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.50
PAM P19021 2/20 0.49
DGKA P23743 1/20 0.48
MAPT P10636 2/20 0.46
MAPK1 P28482 1/20 0.43
TSHR P16473 4/20 0.42
CES2 O00748 3/20 0.42
CES1 P23141 3/20 0.42
ALDH1A1 P00352 3/20 0.41
DNM1 Q05193 1/20 0.41
NAAA Q02083 1/20 0.41
PPARG P37231 4/20 0.41
PPARD Q03181 4/20 0.41
PPARA Q07869 4/20 0.41
GPR84 Q9NQS5 3/20 0.41
HDAC11 Q96DB2 3/20 0.41
TDP1 Q9NUW8 2/20 0.41
SLC22A6 Q4U2R8 1/20 0.41
SLC22A8 Q8TCC7 1/20 0.41
TLR2 O60603 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20918218 1.00 LMNA (0.50) LMNAPAMDGKAMAPTMAPK1
SCHEMBL22092398 1.00 LMNA (0.50) LMNAPAMDGKAMAPTMAPK1
SCHEMBL9101344 1.00 LMNA (0.50) LMNAPAMDGKAMAPTMAPK1
SCHEMBL20918469 1.00 LMNA (0.50) LMNAPAMDGKAMAPTMAPK1
SCHEMBL28018239 0.98 LMNA (0.49) LMNAPAMDGKAMAPTMAPK1
SCHEMBL14695273 0.98 LMNA (0.47) LMNAPAMDGKAMAPTMAPK1
SCHEMBL9768639 0.96 LMNA (0.50) LMNAPAMDGKAMAPTMAPK1
SCHEMBL9768575 0.96 LMNA (0.50) LMNAPAMDGKAMAPTMAPK1
SCHEMBL11586350 0.96 LMNA (0.44) LMNAPAMDGKAMAPTMAPK1
SCHEMBL20919314 0.93 LMNA (0.50) LMNAPAMDGKAMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 395 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022223933-A1 ORGANIC TWO-PHASE COSMETIC COMPOSITION WITH DELAYED PHASE SEPARATION NAOS INSTITUTE OF LIFE SCIENCE (FR) 2022-10-27 WO claimed
EP-4062922-A1 EXTRACT OF SWERTIA CHIRATA AND COSMETIC COMPOSITIONS COMPRISING SAME Chanel Parfums Beauté (FR) 2022-09-28 EP claimed
EP-4035653-A1 OILY EXTRACT FROM GARDENIA JASMINOIDES FLOWERS AND COSMETIC COMPOSITIONS COMPRISING SAME Chanel Parfums Beauté (FR) 2022-08-03 EP claimed
US-20090039177-A1 Spray device for a hair shine composition L'ORAEL S.A. (FR) 2009-02-12 US claimed
US-7101928-B1 Polymeric thickeners for oil-containing compositions LANDEC CORPORATION (US) 2006-09-05 US claimed
US-6989417-B2 Polymeric thickeners for oil-containing compositions LANDEC CORPORATION (US) 2006-01-24 US claimed
CN-122094651-A Composition comprising particle associates 2026-05-26 CN disclosed
EP-4734949-A1 COMPOSITION COMPRISING DIFFERENT EXTRACTS L'OREAL (FR) 2026-05-06 EP disclosed
EP-4731310-A1 COMPOSITION WITH CHITOSAN AND A MODIFIED POLYSACCHARIDE L'OREAL (FR) 2026-04-29 EP disclosed
EP-4731169-A1 COMPOSITION WITH CHITOSAN AND A NATURAL RESIN L'OREAL (FR) 2026-04-29 EP disclosed
EP-4731166-A1 DISPERSIONS COMPRISING PIGMENTS AND AT LEAST TWO LIPOPHILIC GELLING AGENTS Capsum (FR) 2026-04-29 EP disclosed
US-20260096977-A1 Compositions Containing a UV-Absorbing System Including Physical UV-Attenuating Material and Flavone L'OREAL (FR) 2026-04-09 US disclosed
US-20260096964-A1 Emulsions Containing a UV-Absorbing System Including Physical UV-Attenuating Material, Surfactant, and Thickener L'OREAL (FR) 2026-04-09 US disclosed
US-20040156800-A1 Cosmetic composition comprising at least one cyclic carbonate L'OREAL S.A. (FR) 2004-08-12 US disclosed
US-20030007985-A1 Immediate effect anti-wrinkle composition, based on an aqueous dispersion, of at least one mineral filler L'OREAL (FR) 2003-01-09 US disclosed
EP-1112054-A1 RHEOLOGY MODIFIED COMPOSITIONS AND PROCESSES THEREOF HERCULES INCORPORATED (US) 2001-07-04 EP disclosed
WO-2000015180-A1 RHEOLOGY MODIFIED COMPOSITIONS AND PROCESSES THEREOF HERCULES INCORPORATED (US) 2000-03-23 WO disclosed
EP-0893984-A1 COMPOSITIONS CONTAINING COPOLYMERS AS A THICKENING AGENT National Starch and Chemical Investment Holding Corporation (US) 1999-02-03 EP disclosed
WO-1998030194-A2 COMPOSITIONS CONTAINING COPOLYMERS AS A THICKENING AGENT NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) 1998-07-16 WO disclosed
US-5736125-A COSMETICS; OIL STABILITY, STABILITY NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) 1998-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040156800-A1 Cosmetic composition comprising at least one cyclic carbonate POLR1C, NACA, PRKDC LMNA 2239/4885PAM 2997/4885DGKA 1152/4885
US-20260096977-A1 Compositions Containing a UV-Absorbing System Including Physical UV-Attenuating Material and Flavone SOD1, TFEB, KLF5 LMNA 866/4885PAM 4749/4885DGKA 3881/4885
US-20260096964-A1 Emulsions Containing a UV-Absorbing System Including Physical UV-Attenuating Material, Surfactant, and Thickener DSG1, XPA, EXOSC10 LMNA 103/4885PAM 2270/4885DGKA 1377/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.